Defibrotide improves response rate in patients with severe veno-occlusive disease of the liver
Tuesday, December 8, 2009 - 11:42
in Health & Medicine
Defibrotide, a novel drug which modulates the response of blood vessels to injury, was markedly more effective than standard treatment in post-stem cell transplant patients with hepatic veno-occlusive disease, a life threatening toxicity of transplant caused by blockages in tiny blood vessels of the liver, according to a study led by Dana-Farber Cancer Institute scientists.